Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

That is a very insightful article. I

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
PhenixBleu Member Profile
 
Followed By 72
Posts 7,344
Boards Moderated 4
Alias Born 05/06/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2020 6:04:36 AM
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in C... GlobeNewswire Inc. - 9/16/2020 9:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 6:04:19 AM
Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platf... GlobeNewswire Inc. - 9/14/2020 6:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/2/2020 9:10:45 AM
Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-E... GlobeNewswire Inc. - 9/2/2020 9:00:10 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/21/2020 5:27:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/21/2020 4:49:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2020 4:56:30 PM
Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Star... GlobeNewswire Inc. - 8/20/2020 4:05:10 PM
Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2 GlobeNewswire Inc. - 8/19/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:48:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 7:45:15 PM
Sorrento to Take Action Against Hindenburg Research for Statements Believed Intended to Manipulate Stock Price GlobeNewswire Inc. - 8/12/2020 7:51:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/10/2020 6:29:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 6:28:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/4/2020 4:35:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2020 9:02:27 AM
Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva PR Newswire (US) - 7/29/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 9:01:06 AM
Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Star... PR Newswire (US) - 7/24/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 9:01:02 AM
FDA clears Abivertinib for Phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19 PR Newswire (US) - 7/20/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2020 4:41:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2020 4:39:29 PM
PhenixBleu   Friday, 05/15/20 11:23:57 PM
Re: mikar post# 2291
Post # of 6169 
That is a very insightful article. I must say I enjoy how they just put themselves out there today as THE immediate answer to CV-19.

Key quotes below...
Quote:
“Sorrento is in the therapeutic antibody space, and we know it inside out. We have a cGMP facility to get the product onto the market quickly.”


Quote:
“The elderly or an immunocompromised person will have a lack of immune response to a vaccine, but the antibody should provide the instant immunity,” Ji said.


Quote:
If approved, Sorrento expects very large demand. Ji indicates that they can produce hundreds of thousands of doses per run, but the demand could climb into the tens of millions of doses needed. As a result, they are looking for manufacturing partners.


Quote:
“We’re actually so impressed with the data,” Ji said. “One of the antibodies is so powerful that at a very low concentration it is able to 100% completely prevent infection or inhibit the infection. In our studies, not even one virus escaped from the antibody.”


https://www.biospace.com/article/sorrento-ids-antibody-against-covid-19-that-appears-100-percent-effective/

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences